IDH2 and chondrosarcoma: The researchers analyzed plasma samples from patients and identified mutations in the IDH2 gene, with a frequency of approximately 10 %,26 just slightly lower than what the authors found (n = 1/8; 12.5 % of chondrosarcoma cases).